THE PITCH

ANTIBODIES is the buzzword in the race to cure cancer. Naturally produced by our immune systems, they can be used as drugs to bind to target proteins and invoke certain effects, such as destroying...

SINGAPORE-BASED Hummingbird Bioscience has raised US$19 million in a Series B round co-led by Mirae Asset Venture Investment and GNTech Venture Capital, the startup announced in a press release on...